Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study von Chung, Hyun Cheol, Ros, Willeke, Delord, Jean-Pierre, Perets, Ruth, Italiano, Antoine, Shapira-Frommer, Ronnie, Manzuk, Lyudmila, Piha-Paul, Sarina A, Xu, Lei, Zeigenfuss, Susan, Pruitt, Scott K, Leary, Alexandra

Volltext

Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic BRAF -Mutant Melanoma von Delord, Jean-Pierre, Robert, Caroline, Nyakas, Marta, McArthur, Grant A, Kudchakar, Ragini, Mahipal, Amit, Yamada, Yasuhide, Sullivan, Ryan, Arance, Ana, Kefford, Richard F, Carlino, Matteo S, Hidalgo, Manuel, Gomez-Roca, Carlos, Michel, Daniela, Seroutou, Abdelkader, Aslanis, Vassilios, Caponigro, Giordano, Stuart, Darrin D, Moutouh-de Parseval, Laure, Demuth, Tim, Dummer, Reinhard

Volltext

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial von Naumann, R Wendel, Hollebecque, Antoine, Meyer, Tim, Devlin, Michael-John, Oaknin, Ana, Kerger, Joseph, López-Picazo, Jose M, Machiels, Jean-Pascal, Delord, Jean-Pierre, Evans, Thomas R J, Boni, Valentina, Calvo, Emiliano, Topalian, Suzanne L, Chen, Tian, Soumaoro, Ibrahima, Li, Bin, Gu, Junchen, Zwirtes, Ricardo, Moore, Kathleen N

Volltext

Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition von Thibault, Benoît, Castells, Magali, Delord, Jean-Pierre, Couderc, Bettina

Volltext

Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628 von Stathis, Anastasios, Zucca, Emanuele, Bekradda, Mohamed, Gomez-Roca, Carlos, Delord, Jean-Pierre, de La Motte Rouge, Thibault, Uro-Coste, Emmanuelle, de Braud, Filippo, Pelosi, Giuseppe, French, Christopher A

Volltext

Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase II KEYNOTE-158 Study von Strosberg, Jonathan, Mizuno, Nobumasa, Doi, Toshihiko, Grande, Enrique, Delord, Jean-Pierre, Shapira-Frommer, Ronnie, Bergsland, Emily, Shah, Manisha, Fakih, Marwan, Takahashi, Shunji, Piha-Paul, Sarina A, O'Neil, Bert, Thomas, Sajeve, Lolkema, Martijn P, Chen, Menghui, Ibrahim, Nageatte, Norwood, Kevin, Hadoux, Julien

Volltext

PD-1 Blockade in Anaplastic Thyroid Carcinoma von Capdevila, Jaume, Wirth, Lori J, Ernst, Thomas, Ponce Aix, Santiago, Lin, Chia-Chi, Ramlau, Rodryg, Butler, Marcus O, Delord, Jean-Pierre, Gelderblom, Hans, Ascierto, Paolo A, Fasolo, Angelica, Führer, Dagmar, Hütter-Krönke, Marie Luise, Forde, Patrick M, Wrona, Anna, Santoro, Armando, Sadow, Peter M, Szpakowski, Sebastian, Wu, Hongqian, Bostel, Geraldine, Faris, Jason, Cameron, Scott, Varga, Andreea, Taylor, Matthew

Volltext

Implication of tumor microenvironment in chemoresistance: tumor-associated stromal cells protect tumor cells from cell death von Castells, Magali, Thibault, Benoît, Delord, Jean-Pierre, Couderc, Bettina

Volltext

Safety and Antitumor Activity of Pembrolizumab in Patients with Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer von Rugo, Hope S, Delord, Jean-Pierre, Im, Seock-Ah, Ott, Patrick A, Piha-Paul, Sarina A, Bedard, Philippe L, Sachdev, Jasgit, Le Tourneau, Christophe, van Brummelen, Emilie M J, Varga, Andrea, Salgado, Roberto, Loi, Sherene, Saraf, Sanatan, Pietrangelo, Dina, Karantza, Vassiliki, Tan, Antoinette R

Volltext

Improving patient selection for immuno‐oncology phase 1 trials: External validation of six prognostic scores in a French Cancer Center von Al Darazi, Ghassan, Martin, Elodie, Delord, Jean‐Pierre, Korakis, Iphigenia, Betrian, Sarah, Estrabaut, Myriam, Poublanc, Muriel, Gomez‐Roca, Carlos, Filleron, Thomas

Volltext

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, c... von Le Tourneau, Christophe, Dr, Delord, Jean-Pierre, Prof, Gonçalves, Anthony, Prof, Gavoille, Céline, MD, Dubot, Coraline, MD, Isambert, Nicolas, MD, Campone, Mario, Prof, Trédan, Olivier, MD, Massiani, Marie-Ange, MD, Mauborgne, Cécile, MSc, Armanet, Sebastien, MSc, Servant, Nicolas, PhD, Bièche, Ivan, PhD, Bernard, Virginie, PhD, Gentien, David, PhD, Jezequel, Pascal, MD, Attignon, Valéry, PhD, Boyault, Sandrine, PhD, Vincent-Salomon, Anne, MD, Servois, Vincent, MD, Sablin, Marie-Paule, MD, Kamal, Maud, PhD, Paoletti, Xavier, PhD

Volltext

Phase 1 study of the immunotoxin LMB‐100 in patients with mesothelioma and other solid tumors expressing mesothelin von Hassan, Raffit, Alewine, Christine, Mian, Idrees, Spreafico, Anna, Siu, Lillian L., Gomez‐Roca, Carlos, Delord, Jean‐Pierre, Italiano, Antoine, Lassen, Ulrik, Soria, Jean‐Charles, Bahleda, Rastilav, Thomas, Anish, Steinberg, Seth M., Peer, Cody J., Figg, William D., Niederfellner, Gerhard, Méresse Naegelen, Valérie, Pastan, Ira

Volltext

Pharmacokinetics (PK) of Tiragolumab in First‐in‐Human Study in Patients with Mixed Solid Tumors (GO30103) von Garralda, Elena, Oh, Do Youn, Italiano, Antoine, Bedard, Philippe L., Delord, Jean‐Pierre, Calvo, Emiliano, LoRusso, Patricia, Wainberg, Zev, Cervantes, Andres, Rodriguez‐Vida, Alejo, Shemesh, Colby S., Sane, Rucha, Mendus, Diana, Ding, Hao, Hendricks, Robert, Meng, Ray, Cho, Byoung Chul, Kim, Tae Won, Wu, Benjamin

Volltext

CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study von Cassier, Philippe A, MD, Italiano, Antoine, Dr, Gomez-Roca, Carlos A, MD, Le Tourneau, Christophe, MD, Toulmonde, Maud, MD, Cannarile, Michael A, PhD, Ries, Carola, PhD, Brillouet, Anne, BSc, Müller, Claudia, PhD, Jegg, Anna-Maria, PhD, Bröske, Ann-Marie, PhD, Dembowski, Markus, PhD, Bray-French, Katharine, PhD, Freilinger, Christine, PhD, Meneses-Lorente, Georgina, PhD, Baehner, Monika, PhD, Harding, Ross, PhD, Ratnayake, Jayantha, PhD, Abiraj, Keelara, PhD, Gass, Nathalie, PhD, Noh, Karen, PharmD, Christen, Randolph D, MD, Ukarma, Lidia, MD, Bompas, Emmanuelle, MD, Delord, Jean-Pierre, Prof, Blay, Jean-Yves, Prof, Rüttinger, Dominik, MD

Volltext

Cetuximab pharmacokinetic/pharmacodynamics relationships in advanced head and neck carcinoma patients von Le Louedec, Félicien, Alix‐Panabières, Catherine, Lafont, Thierry, Allal, Ben C., Garrel, Renaud, Digue, Laurence, Guigay, Joël, Cupissol, Didier, Delord, Jean‐Pierre, Lallemant, Benjamin, Alfonsi, Marc, Aubry, Karine, Mazel, Martine, Becher, François, Perriard, Françoise, Chatelut, Etienne, Thomas, Fabienne

Volltext

Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies von Sibaud, Vincent, Meyer, Nicolas, Lamant, Laurence, Vigarios, Emmanuelle, Mazieres, Julien, Delord, Jean Pierre

Volltext

A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO p... von Gravis, Gwenaelle, Marino, Patricia, Olive, Daniel, Penault-LLorca, Frederique, Delord, Jean-Pierre, Simon, Clotilde, Lamrani-Ghaouti, Assia, Sabatier, Renaud, Ciccolini, Joseph, Boher, Jean-Marie

Volltext

Characteristics and Clinical Outcomes of Sarcomatoid Carcinoma of the Lung von Ung, Mony, Rouquette, Isabelle, Filleron, Thomas, Taillandy, Kristell, Brouchet, Laurent, Bennouna, Jaafar, Delord, Jean-Pierre, Milia, Julie, Mazières, Julien

Volltext

Improving communication between the general practitioner and the oncologist: a key role in coordinating care for patients suffering from cancer von Druel, Vladimir, Gimenez, Laetitia, Paricaud, Kim, Delord, Jean-Pierre, Grosclaude, Pascale, Boussier, Nathalie, Bugat, Marie-Eve Rougé

Volltext

Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simulta... von Laprie, Anne, Ken, Soléakhéna, Filleron, Thomas, Lubrano, Vincent, Vieillevigne, Laure, Tensaouti, Fatima, Catalaa, Isabelle, Boetto, Sergio, Khalifa, Jonathan, Attal, Justine, Peyraga, Guillaume, Gomez-Roca, Carlos, Uro-Coste, Emmanuelle, Noel, Georges, Truc, Gilles, Sunyach, Marie-Pierre, Magné, Nicolas, Charissoux, Marie, Supiot, Stéphane, Bernier, Valérie, Mounier, Muriel, Poublanc, Muriel, Fabre, Amandine, Delord, Jean-Pierre, Cohen-Jonathan Moyal, Elizabeth

Volltext